Monday 16 November 2026
Export BRVE’s income statement to Excel — free account
Braveheart Bio, Inc.
BRVE- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
19.62
0.88
−4.29%
Follow BRVE
Alert me
What it owns vs. what it owes Q3 FY2026, 30 September 2026
It holds $503.4M more in cash and investments than it owes in debt. Shareholders’ equity is 97% of the balance sheet. What is a balance sheet?
Owns
$628.0KLong-term assets
$10.3MOther short-term assets
$503.5MCash & all investments
Funded by
$497.6MShareholders’ equity
$16.7MOther liabilities
$100.0KDebt
Debt is 0.0% of the total; shareholders’ equity 96.7%.
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
349.27 | 122.83 | 80.58 | 89.16 |
+2 more quarters Free account |
Total current assets |
359.57 | 123.45 | 81.07 | 89.28 | |
Property, Plant, Equpment (Net) |
0.02 | 0.02 | 0.03 | — | |
Long-Term Investments |
154.25 | — | — | — | |
Long-term assets (Other) |
0.10 | 0.07 | 0.07 | 0.07 | |
Total non-current assets |
154.88 | 3.51 | 0.81 | 0.07 | |
Total Assets |
514.45 | 126.96 | 81.88 | 89.35 | |
Accounts Payable |
1.98 | 2.67 | 7.74 | 1.06 | |
Accrued Expenses |
8.14 | 6.01 | 1.89 | 4.18 | |
Current Part of Capital Lease |
0.42 | 0.38 | 0.37 | — | |
Other current liabilities |
6.15 | — | — | — | |
Total current liabilities |
16.67 | 9.06 | 10.00 | 5.24 | |
Long Term Debt (Total) |
0.10 | 0.20 | 0.29 | — | |
Preferred Shares of Subsidiary (Mandatory, Redeemable) |
— | 213.52 | 149.89 | 149.89 | |
Non-current Liabilities (Other) |
0.08 | 0.09 | 0.09 | 0.09 | |
Total non-current liabilities |
0.18 | 213.80 | 150.27 | 149.98 | |
Total liabilities |
16.85 | 222.86 | 160.27 | 155.22 | |
Additional Paid In Capital |
620.71 | — | 1.94 | 0.18 | |
Common Stock (Net) |
0.01 | 0.00 | 0.00 | 0.00 | |
Retained Earnings |
(122.40) | (95.91) | (80.33) | (66.05) | |
Common Equity (Total) |
497.60 | (95.91) | (78.39) | (65.87) | |
Shareholders Equity (Total) |
497.60 | (95.91) | (78.39) | (65.87) | |
Shareholders Equity and Liabilities (Total) |
514.45 | 126.96 | 81.88 | 89.35 | |
Shares (Common) |
82.07 | 7.54 | 6.96 | 6.69 | |
Shareholders Equity (Tangible) |
497.60 | (95.91) | (78.39) | (65.87) | |
Net Debt |
(349.17) | (122.63) | (80.28) | (89.16) | |
Total Debt |
0.10 | 0.20 | 0.29 | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 12 Nov 2026